A method of modulating the function of a serine/threonine protein kinase with a pyrido[2,3-b]pyrazine-based compound, comprising contacting cells expressing the serine/threonine protein kinase with the compound, wherein the pyrido[2,3-b]pyrazine-based compound has the formula set forth in structure I:
- wherein
- (a) R1, R2, R3, R4 and R6 are independently selected from the group consisting of
- (i) hydrogen;
- (ii) saturated alkyl or unsaturated alkyl, optionally substituted with a five-membered aryl, six-membered aryl, five-membered heteroaryl, or six-membered heteroaryl ring moiety, wherein the ring moiety is optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl halogen, trihalomethyl, carboxylate, nitro, and ester moieties;
- (iii) an amine of formula —NX2X3, wherein X2 and X3 are independently selected from the group consisting of hydrogen, saturated alkyl, unsaturated alkyl, five-membered aryl, six-membered aryl, five-membered heteroaryl, and six-membered heteroaryl moieties;
- (iv) halogen or trihalomethyl;
- (v) a ketone of formula —CO—X4, wherein X4 is selected from the group consisting of hydrogen, alkyl, five-membered aryl, and five-membered heteroaryl moieties;
- (vi) a carboxylic acid of formula —(X5)n—COOH or an ester of formula —(X6)n—COO—X7, wherein X5, X6 and X7 are independently selected from the group consisting of alkyl, five-membered aryl, six-membered aryl, five-membered heteroaryl, and six-membered heteroaryl moieties, and wherein n is 0 or 1;
- (vii) an alcohol of formula (X8)n—OH or an alkoxy moiety of formula —(X8)n—O—X9, wherein X8 and X9 are independently selected from the group consisting of hydrogen, saturated alkyl, unsaturated alkyl, five-membered aryl, six-membered aryl, five-membered heteroaryl, and six-membered heteroaryl ring moieties, wherein the ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester, and wherein n is 0 or 1;
- (viii) an amide of formula —NHCOX10, wherein X10 is selected from the group consisting of alkyl, hydroxyl, five-membered aryl, six-membered aryl, five-membered heteroaryl, and six-membered heteroaryl moieties, wherein the ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester;
- (ix) —SO2NX11X12, where X11 and X12 are independently selected from the group consisting of hydrogen, alkyl, five-membered aryl, six-membered aryl, five-membered heteroaryl, and six-membered heteroaryl moieties;
- (x) a five-membered aryl, six-membered aryl, five-membered heteroaryl, or six-membered heteroaryl moiety optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester moieties;
- (xi) an aldehyde of formula —CO—H;
- and
- (xii) a sulfone of formula —SO2—X13, where X13 is selected from the group consisting of saturated alkyl, unsaturated alkyl, five-membered aryl, six-membered aryl, five-membered heteroaryl, and six-membered heteroaryl moieties;
- and
- (b) X1 is selected from the group consisting of NH, S and O.